High affinity human antibodies to human angiopoietin-2

Antibody against human NRG1 protein

Immunoglobulin constant region Fc receptor binding agents

Methods of treating PRLR positive breast cancer

Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2

Bispecific antigen-binding constructs targeting HER2

ANTIBODY FORMULATION

TRAILR2 CDH17 binding molecules for the treatment of cancer

LIGAND-CYTOTOXIC DRUG CONJUGATE, PREPARATION METHOD THEREOF, AND USE THEREOF

Isoquinolidinobenzodiazepine (IQB)-1(chloromethyl)-2,3-dihydro-1H-benzo[e]indole (CBI) dimers

Afucosylated protein, cell expressing said protein and associated methods

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND AN ANTI-CD20 ANTIBODY

Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same

Anti-OX40 antibodies and their uses

Therapeutic CD47 antibodies

JAM-C antibodies and methods for treatment of cancer

CD123 antibodies and conjugates thereof

Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

Anti-NTB-A antibodies and related compositions and methods

Conjugated compounds comprising cysteine-engineered antibodies

PSMA targeting trispecific proteins and methods of use

CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities

Subcutaneous anti-HLA-DR monoclonal antibody for treatment of hematologic malignancies

CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF

Antibodies specific for claudin 6 (CLDN6)

Compounds

COMPOSITIONS AND METHODS RELATING TO INHIBITING CANCER CELL GROWTH AND/OR PROLIFERATION

Libraries of modified fibronectin type III tenth domain-containing polypeptides

Prostate specific membrane antigen binding protein

Methods for expansion or depletion of t-regulatory cells

Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation

Anti-ADAM28 antibody for treating cancer

DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-ITM2A ANTIBODY

Antibodies against human and canine IL-13RA2

Anti-human-HER3 antibodies and uses thereof

BTLA Antibodies and Uses Thereof

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

Antibodies

DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

METHOD FOR THE TREATMENT OR PREVENTION OF INFECTION-RELATED IMMUNE CONDITIONS USING A COMPOSITION COMPRISING IGM

Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor

Masking chimeric antigen receptor T cells for tumor-specific activation

Methods of using bispecific CD33 and CD3 binding proteins

TGF-β3 specific antibodies and methods and uses thereof

Bispecific molecules comprising an HIV-1 envelope targeting arm

ANTIGEN BINDING PROTEINS

ANTI-ROR1 CHIMERIC ANTIGEN RECEPTORS

Chimeric antigen receptors and uses thereof

ANTI-LAMP1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES, AND USES THEREOF

ANTIBODIES TO CD40

Compositions monovalent for CD28 binding and methods of use

Bispecific antibody constructs for CDH3 and CD3

Derivatives of dolastatin 10 and uses thereof

Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor

Human monoclonal antibodies specific for glypican-3 and use thereof

Anti-MET antibodies, bispecific antigen binding molecules that bind MET, and methods of use thereof

Antibodies reactive with B7-H3 and users thereof

Antibody agents specific for human CD19 and uses thereof

Methods of treating Alzheimer's disease

Internalizing moieties for treatment of cancer

Anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody and methods of use thereof for detecting VEGFR2 and for inhibiting tumor growth, tumor angiogenesis and/or inducing cancer cell cytotoxicity

PD-1 immune modulating agents

Humanization of rabbit antibodies using a universal antibody framework

Monoclonal antibodies against claudin-18 for treatment of cancer

Anti-EGFR antibodies and antibody drug conjugates

Therapeutic combinations comprising anti-CD73 antibodies and uses thereof

Treatment of ocular neovascularization using anti-VEGF proteins

Anti-MUC16 antibodies

Disease therapy by inducing immune response to Trop-2 expressing cells

Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4

Bispecific checkpoint inhibitor antibodies

Heterodimeric antibodies that bind somatostatin receptor 2

Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof

Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof

IL15/IL15Rα heterodimeric Fc-fusion proteins

GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS

Chimeric antigen receptors targeting G-protein coupled receptor and uses thereof

RECOMBINANT PRODUCTION OF MIXTURES OF ANTIBODIES

T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

Anti-MUC16 antibodies and uses thereof

Modulators of ROR1-ROR2 binding

Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Dual specific anti-CD22-anti-CD19 chimeric antigen receptors

Monoclonal antibody and antigens for diagnosing and treating lung disease and injury

METHODS, COMPOSITIONS AND APPARATUSES FOR FACILITATING REGENERATION

Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof

Immune conjugate having dendron conjugated to antibody and use thereof

Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)

Anti-CD133 monoclonal antibodies and related compositions and methods

Anti-CD47 antibodies and methods of use

PROSTATE-SPECIFIC MEMBRANE ANTIGEN BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS

Fc containing polypeptides with altered glycosylation and reduced effector function

RECOMBINANT PRODUCTION OF MIXTURES OF ANTIBODIES

Bispecific antibodies that bind to CD38 and CD3

ANTI-PTK7 ANTIBODY-DRUG CONJUGATES

Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof

Antagonist antibodies to human prolactin receptor (PRLR)

Anti-HER2 antibodies and methods of use

ANTIBODIES THAT BIND CELL SURFACE GRP78 AND THEIR USE FOR DETECTION OF CANCER

Antibodies that bind interleukin-2 and uses thereof

High affinity antibodies that neutralize enterotoxin B

CD48 antibodies and conjugates thereof

Methods of treating psoriasis using PD-1 binding antibodies

Methods for controlling fucosylation levels in proteins

Bispecific T cell activating antigen binding molecules

Anti-IL-6/IL-6R antibodies and methods of use thereof

Anti-plasmodium parasite antibodies

Antibody/T-cell receptor chimeric constructs and uses thereof

Antibody specifically binding to ErbB3 and use thereof

Universal immune cells for cancer immunotherapy

CANCER MARKER AND THE USE THEREOF

Anti-CD123 antibodies and conjugates and derivatives thereof

METHOD OF INHIBITION OF LEUKEMIC STEM CELLS

Multivalent Antibody Complexes Targeting IGF-1R Show Potent Toxicity Against Solid Tumors

Anti-human vista antibodies and use thereof

Bispecific antigen binding proteins

Trispecific binding molecules for treating HBV infection and associated conditions

IL2 and TNF immunoconjugates

Conjugates for the treatment of cancer targeted at intracellular tumor-associated antigens

Carbonic anhydrase IX (G250) antibodies and methods of use thereof

Anti-CSPG4 reagents and methods of treating cancer

Method of treating cancer with humanized anti-OX40 antibodies

Recombinant TNF ligand family member polypeptides with antibody binding domain and uses thereof

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

Stable and soluble antibodies inhibiting VEGF

Anti-netrin-1 antibody

Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides

POLYPEPTIDE THAT BINDS ABERRANT CELLS AND INDUCES APOPTOSIS

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

Anti-TIGIT antibodies

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Nucleic acids encoding agonistic antibodies that bind CD40

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

METHODS OF TREATING MENINGIOMA

COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS

BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)

Anti-MET Antibodies and Methods of Use Thereof

MASKED ANTI-CD3 ANTIBODIES AND METHODS OF USE

Therapeutic CD47 antibodies

NOVEL ANTIBODY-ALBUMIN-DRUG CONJUGATES (AADC) AND METHODS FOR USING THEM

VACCINE, THERAPEUTIC COMPOSITION AND METHODS FOR TREATING OR INHIBITING CANCER

Chimeric antigen receptors targeting B-cell maturation antigen

Anti-PD-1 checkpoint inhibitor antibodies that block binding of PD-L1 to PD-1

Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditions

Therapeutic CD47 antibodies

Treatment of cancer using a CD33 chimeric antigen receptor

Chimeric antigen receptor (CAR) comprising a CD19-binding domain

Methods, compositions and apparatuses for facilitating regeneration

Anti-glucosaminidase passive immunization for infections

PERTUZUMAB VARIANTS AND EVALUATION THEREOF

PERTUZUMAB VARIANTS AND EVALUATION THEREOF

Pertuzumab variants and evaluation thereof

Antibody drug conjugates (ADC) that bind to FLT3 proteins

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use

Antibody-drug conjugate

Methods of delivering DLL3 antibody drug conjugates

Methods of making DLL3 antibody drug conjugates

Anti-ErbB3 antibodies and uses thereof

Anti-EGFR Antibodies and Uses Thereof

Anti-ERBB3 antibodies

Uses of indolinone compounds

Adoptive T-cell therapy using EMPD-specific chimeric antigen receptors for treating IgE-mediated allergic diseases

Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide

METHODS AND PRODUCTS FOR PREVENTING AND/OR TREATING METASTATIC CANCER

Anti-CEACAM5 antibodies and uses thereof

Antigen binding complex having agonistic activity and methods of use

Bispecific binding proteins and uses thereof

Markers of acute myeloid leukemia stem cells

Monoclonal antibodies to progastrin and their uses

Bispecific antibody capable of being combined with immune cells to enhance tumor killing capability, and preparation method therefor and application thereof

Method of treating cancer by administering tumor necrosis factor receptor ligand superfamily (TNFRSF) single-chain polypeptides

Methods for treating back or neck pain caused by NGF using a therapeutic agent comprising REN-1820, ALE-0540 and capsaicin

Antigen binding molecules and methods of use thereof

Domain-exchanged antibody

Method for obtaining high-yield, stable expression cell clones and antibody molecules obtained thereby

Multivalent molecules comprising DR5-binding domains

Methods for the treatment of interleukin-6 receptor-related diseases and disorders

SOLUBLE MIC NEUTRALIZING MONOCLONAL ANTIBODY FOR TREATING CANCER

ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME

Anti-DLL3 antibody drug conjugates and methods of use

Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof

Method and compositions for cellular immunotherapy

Antibodies against notch 3

FRIZZLED 2 AS A TARGET FOR THERAPEUTIC ANTIBODIES IN THE TREATMENT OF CANCER

Antibody constructs for CDH19 and CD3

Antigen-binding constructs that bind to and inhibit catalase and/or superoxide dismutase as well as pharmaceutical compositions containing them for tumor therapy

Anti-MERTK agonistic antibodies and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Anti-CXCR4 antibodies and antibody-drug conjugates

Human monoclonal antibodies against orexin receptor type 1

CD33 specific chimeric antigen receptors

Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer

Multispecific antibodies

BISPECIFIC ANTIBODIES AGAINST HER2 AND CD3

BISPECIFIC ANTIBODIES AGAINST HER2

PRO-APOPTOTIC ANTI-NG2/CSPG4 ANTIBODIES AND THEIR USES FOR DISEASE THERAPY

Bispecific tetravalent antibodies and methods of making and using thereof

Anti-CD276 polypeptides, proteins, and chimeric antigen receptors

Antibodies to CD70

Antibodies directed against CD4 for the treatment and functional cure of HIV

Anti-CD47 antibodies and uses thereof

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

Anti-DLL3 antibody drug conjugates

Cancer treatment combinations

Multispecific and multifunctional molecules and uses thereof

Treatment of angiogenesis disorders

Antibodies against immunogenic glycopeptides, compositions comprising the same and use thereof

Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use

ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVATIVES THEREOF FOR USE IN TREATING BONE ASSOCIATED PAIN

COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR HEMATOPOIETIC ORIGIN

Method of treating autoimmune disease by administering antibodies to interleukin-6

Human anti-IL-23 antibodies, compositions, methods and uses

Cysteine linked nanobody dimers

Methods for the depletion of CD117+ cells

Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers

ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE (CEACAM)

COMPOSITIONS AND METHODS OF TREATING TUMORS

COMBINATION OF ANTI-CS1 AND ANTI-PD1 ANTIBODIES TO TREAT CANCER (MYELOMA)

Bispecific antibodies against CD3 and CD20

High-throughput screening of functional antibody fragments, immunoconjugate comprising the same, and adaptor-drug conjugate for screening

Optimized cross-species specific bispecific single chain antibody contructs

C-MET ANTIBODY COMBINATIONS

Combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists

ANTI-CD52 ANTIBODIES

Methods and compositions for cancer treating conditions relating to over expressions of EphA2

Anti-Axl antagonistic antibodies

BISPECIFIC ANTIBODIES THAT BIND CD20 AND CD3

Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof

Methods for formulating antibody drug conjugate compositions

Use of marizomib for the treatment of central nervous system (CNS) cancers

NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER

Antibody binding to carbonic anhydrase and use thereof

Fusion polypeptide capable of binding simultaneously to VEGF-C and VEGF-D

Anti-NGF antibodies and methods using same

Immunotherapy against ErbB-3 receptor

Construction and characterization of multimeric IL-15-based molecules with CD3 binding domains

METHOD TO PREDICT THE LACK OF RESPONSE TO ANTI-TNF ALPHA THERAPIES

Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases

Antibody molecules for cancer treatment

Treatment of pediatric BCP-ALL patients with an anti-KIR antibody

Bak binding proteins

Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

Chimeric antigen receptors (CAR) to selectively target protein complexes

Treatment of cancer using GFR α-4 chimeric antigen receptor

ANTI-TUMOR ANTIBODY-TUMOR SUPPRESSOR FUSION PROTEIN COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT OF CANCER

Rodent bispecific heterodimeric proteins

IgM and IgE heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity

Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor

Methods of treating skin cancer by administering a PD-1 inhibitor

BISPECIFIC ANTIBODIES AGAINST CD3 EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES

Folate receptor 1 antibodies and immunoconjugates and uses thereof

COMBINATION OF ANTI-PD-1 ANTIBODIES AND RADIATION TO TREAT CANCER

CROSSLINKING OF CD22 BY EPRATUZUMAB TRIGGERS BCR SIGNALING AND CASPASE-DEPENDENT APOPTOSIS IN HEMATOPOIETIC CANCER CELLS

Methods of Treating Autoimmune Diseases

Trispecific and/or trivalent binding proteins

Humanized monoclonal antibody and uses thereof

Anti-MFI2 antibodies and methods of use

MULTIVALENT AND MULTISPECIFIC GITR-BINDING FUSION PROTEINS

Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies

Antibodies against human CSF-1R and uses thereof

Anti-vista antibodies and fragments, uses thereof, and methods of identifying same

Methods for manipulating phagocytosis mediated by CD47

Anti-NTB-A antibodies and related compositions and methods

CS1-specific chimeric antigen receptor engineered immune effector cells

Use of antibodies for enrichment of engineered T cells with exogenous immune receptors and antibodies for use in depletion of engineered T cells

Engineered polypeptide conjugates and methods for making thereof using transglutaminase

Antibodies that specifically bind to TIM3

METHODS AND COMPOSITIONS PERTAINING TO HUMAN CEREBRAL CAVERNOUS MALFORMATIONS

Antibody for Recognizing Specific Motif of WLS Protein, and Pharmaceutical Composition Comprising Same

Kits containing DLL3 antibody drug conjugates

Anti-HER3 antibodies and uses of same

Antibody therapeutics that bind STAT3

GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

Prostate-specific membrane antigen binding proteins and related compositions and methods

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TREATMENT OF OVARIAN CANCER

Bispecific antibodies against CD3ϵ and BCMA

Antibodies against OX40 and uses thereof

Anti-human vista antibodies and use thereof

Anti-human vista antibodies and use thereof

Anti-human vista antibodies and use thereof

Bispecific antibodies against CD3EPSILON and ROR1

Anti-CD100 antibodies and methods for using the same

CROSS REACTIVE SIGLEC ANTIBODIES

Monoclonal antibodies to progastrin and their uses

Monoclonal antibodies to progastrin and their uses

Cell culture medium

EGFR and c-Met fibronectin type III domain binding molecules

Antagonistic DR3 Ligands

Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

Bispecific antibodies for use in stem cell transplantation

RSPO BINDING AGENTS AND USES THEREOF

Antibodies to GRP78

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

Multivalent and monovalent multispecific complexes and their uses

USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BASAL-LIKE BREAST CANCERS

Carrier-binding agent compositions and methods of making and using the same

Anti-LIGHT antibodies